Cargando…
Comparing the Efficacy of Ceftazidime and Meropenem in Treatment of Febrile Neutropenia in Pediatric Patients with Cancer
BACKGROUND: In cancer patients, various infections were developed due to severe neutropenia resulted from chemotherapy. Ceftazidime is commonly used as monotherapy of cancer patients with fever and neutropenia. Meropenem is a new carbapenem with more extended antibacterial spectrum including anaerob...
Autores principales: | Ferdosian, F, Ghiliyan, R, Hashemi, A, Akhondzadeh, B, Gholampoor, E |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Shahid Sadoughi University of Medical Sciences
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3921881/ https://www.ncbi.nlm.nih.gov/pubmed/24575280 |
Ejemplares similares
-
Meta-analysis: combination of meropenem vs ceftazidime and amikacin for empirical treatment of cancer patients with febrile neutropenia
por: Wang, Ying, et al.
Publicado: (2021) -
374 Indication-based Antimicrobial Derestriction: Ceftazidime Derestriction for Febrile Neutropenia
por: Nash, Colleen B., et al.
Publicado: (2014) -
Evaluating the Use of Meropenem in Hematologic Patients with Febrile Neutropenia: A Retrospective Observational Single-Cohort Study
por: Stuurman, R.A., et al.
Publicado: (2023) -
Ceftazidime–Avibactam versus Meropenem for the Treatment of Complicated Intra-Abdominal Infections
por: Tan, Che-Kim, et al.
Publicado: (2019) -
Prevalence of Fungemia in Pediatric Patients with Febrile Neutropenia
por: Meidani, Mohsen, et al.
Publicado: (2018)